BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8615125)

  • 1. Neurotoxicity and the mechanisms of cell death in Parkinson's disease.
    Schapira AH
    Adv Neurol; 1996; 69():161-5. PubMed ID: 8615125
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental models of Parkinson's disease].
    Féger J; Pessigliore M; François C; Tremblay L; Hirsch E
    Ann Pharm Fr; 2002 Jan; 60(1):3-21. PubMed ID: 11976545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective therapy for Parkinson's disease.
    Koller WC
    Exp Neurol; 1997 Mar; 144(1):24-8. PubMed ID: 9126147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative mechanisms in nigral cell death in Parkinson's disease.
    Jenner P
    Mov Disord; 1998; 13 Suppl 1():24-34. PubMed ID: 9613715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis and Parkinson's disease.
    Lev N; Melamed E; Offen D
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):245-50. PubMed ID: 12657363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is dopaminergic cell death accompanied by concomitant nerve plasticity?
    Anglade P; Blanchard V; Raisman-Vozari R; Faucheux BA; Herrero MT; Obeso JA; Mouatt-Prigent A; Kastner A; Strada O; Javoy-Agid F; Agid Y; Hirsch EC
    Adv Neurol; 1996; 69():195-208. PubMed ID: 8615129
    [No Abstract]   [Full Text] [Related]  

  • 7. Transmitter receptor alterations in Parkinson's disease.
    Calne DB; Stoessl AJ
    Adv Neurol; 1987; 45():45-9. PubMed ID: 2881449
    [No Abstract]   [Full Text] [Related]  

  • 8. Activation of adenosine triphosphate-sensitive potassium channels confers protection against rotenone-induced cell death: therapeutic implications for Parkinson's disease.
    Tai KK; Truong DD
    J Neurosci Res; 2002 Aug; 69(4):559-66. PubMed ID: 12210849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxins, genetics, and Parkinson's disease: the role of N-acetyltransferase 2.
    Bandmann O; Vaughan J; Holmans PA; Marsden CD; Wood NW
    Adv Neurol; 1999; 80():199-204. PubMed ID: 10410722
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic and environmental factors in the pathogenesis of Parkinson's disease.
    Mizuno Y; Shimoda-Matsubayashi S; Matsumine H; Morikawa N; Hattori N; Kondo T
    Adv Neurol; 1999; 80():171-9. PubMed ID: 10410718
    [No Abstract]   [Full Text] [Related]  

  • 11. Neurotoxicity of nicotinamide derivatives: their role in the aetiology of Parkinson's disease.
    Willets JM; Lunec J; Williams AC; Griffiths HR
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):299S. PubMed ID: 8224447
    [No Abstract]   [Full Text] [Related]  

  • 12. Iron metabolism and Parkinson's disease.
    Hirsch EC; Faucheux BA
    Mov Disord; 1998; 13 Suppl 1():39-45. PubMed ID: 9613717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of zebrafish to environmental toxins implicated in Parkinson's disease.
    Bretaud S; Lee S; Guo S
    Neurotoxicol Teratol; 2004; 26(6):857-64. PubMed ID: 15451049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Parkinson's complex: parkinsonism is just the tip of the iceberg.
    Langston JW
    Ann Neurol; 2006 Apr; 59(4):591-6. PubMed ID: 16566021
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurotoxicant-induced animal models of Parkinson's disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration.
    Uversky VN
    Cell Tissue Res; 2004 Oct; 318(1):225-41. PubMed ID: 15258850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of Parkinson's disease.
    Br Med J; 1978 Apr; 1(6117):872-3. PubMed ID: 25109
    [No Abstract]   [Full Text] [Related]  

  • 17. The parkinsonism producing neurotoxin MPP+ affects microtubule dynamics by acting as a destabilising factor.
    Cappelletti G; Surrey T; Maci R
    FEBS Lett; 2005 Aug; 579(21):4781-6. PubMed ID: 16098973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress and neurotoxicity.
    Sayre LM; Perry G; Smith MA
    Chem Res Toxicol; 2008 Jan; 21(1):172-88. PubMed ID: 18052107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuronal death and growth factors: new therapeutic approaches in Parkinson's disease].
    Wider C; Burkhard PR; Sajadi A; Vingerhoets FJ
    Rev Med Suisse; 2006 May; 2(64):1158-62. PubMed ID: 16734187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neurochemistry of Parkinson's disease--comments on present and future developments.
    Hucho F
    J Neural Transm Suppl; 1995; 46():59-65. PubMed ID: 8821041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.